Glaukos Corporation (GKOS) vs Smith & Nephew SNATS, Inc. (SNN)

Glaukos Corporation and Smith & Nephew SNATS, Inc. are both Medical Devices companies. Smith & Nephew SNATS, Inc. is the larger, with a market value of $11.2B against $9.1B — 1.2× the size. Glaukos Corporation has negative trailing earnings, so its P/E is not meaningful; Smith & Nephew SNATS, Inc. trades at 32.8×. Glaukos Corporation grew revenue faster over the last twelve months: 41.6% against 4.81%. Smith & Nephew SNATS, Inc. has the higher net margin (6.71% vs −30.7%) and the higher return on invested capital (0.00% vs −26.1%). Across the 19 metrics below, Smith & Nephew SNATS, Inc. leads on 13 and Glaukos Corporation on 6.

Valuation

Metric GKOS SNN Medical Devices median
P/E n/m 32.80 22.18
P/S 14.82 1.15 2.70
P/B 13.31 2.33 2.46
Price to free cash flow n/m 5.97 22.53
EV/EBITDA n/m 5.66 11.78
EV/Sales 14.46 1.39 2.38
Earnings yield (2.10%) 3.05% (8.22%)
Free cash flow yield (0.13%) 16.74% (7.80%)

Profitability

Metric GKOS SNN Medical Devices median
Gross margin 79.12% 70.52% 56.01%
Operating margin (31.55%) 0.00% (15.03%)
Net margin (30.68%) 6.71% (20.40%)
Free cash flow margin (1.99%) 0.00% (7.24%)
Return on equity (25.98%) 0.00% (15.32%)
Return on assets (19.72%) 0.00% (19.72%)
Return on invested capital (26.07%) 0.00% (10.33%)

Growth

Metric GKOS SNN Medical Devices median
Revenue growth (TTM) 41.55% 4.81% 8.80%
EPS growth (last fiscal year) (18.41%) 52.34% —
Revenue growth, 5-year CAGR 17.67% 6.21% 15.23%
Net income growth, 5-year CAGR 0.00% 6.89% 0.00%

Health

Metric GKOS SNN Medical Devices median
Debt to equity 0.10 0.62 0.07
Current ratio 5.04 2.14 2.50
Net debt to EBITDA 1.31 1.92 0.49

Dividend

Metric GKOS SNN Medical Devices median
Dividend yield — 2.67% 0.94%
Payout ratio 0.00 1.50 0.00

Size

Metric GKOS SNN Medical Devices median
Market cap 9.14b 11.17b 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack